Mardia Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.76 M
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.25 M
- Satisfied Charges ₹ 0.75 M
- Revenue Growth %
- Profit Growth 6.55%
- Ebitda 31.85%
- Net Worth -0.74%
- Total Assets -1.86%
About Mardia Pharmaceuticals
Mardia Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 May 1985 and has a history of 39 years and eight months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.76 M.
The company currently has active open charges totaling ₹2.25 M. The company has closed loans amounting to ₹0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Mardia and Kanta Mardia serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1985PTC036381
- Company No.
036381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mardia Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Mardia  | Director | 26-Jul-1999 | Current |
| Kanta Mardia | Director | 26-Jul-1999 | Current |
Financial Performance of Mardia Pharmaceuticals.
Mardia Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.55% increase in profit. The company's net worth dipped by a decrease of 0.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mardia Pharmaceuticals?
In 2019, Mardia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hrinkar Pharma India Private LimitedGeeta Mardia is a mutual person
Charges (Loans)
₹2.25 M
₹0.75 M
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jul 1995 | Syndicate Bank | ₹0.75 M | Open |
| 07 Jul 1995 | Syndicate Bank | ₹1.50 M | Open |
| 14 Jul 1995 | Syndicate Bank | ₹0.75 M | Satisfied |
How Many Employees Work at Mardia Pharmaceuticals?
Unlock and access historical data on people associated with Mardia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mardia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mardia Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
